Prevention of RSV Infections in Bone Marrow Transplant Recipients

NCT00001903 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

NIH

Sponsor class

Conditions

Respiratory Syncytial Virus Infection

Interventions

DRUG: RSV Polyclonal Immunoglobulin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)